78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock moved upwards by 17.2% to $0.7 during Friday's after-market session. The company's market cap stands at $14.5 million.
41 Stocks Moving In Friday’s Mid-Day Session
Gainers
Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday.
Recap: Applied DNA Sciences Q1 Earnings
Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Applied DNA Sciences Q1 EPS $(0.63) Misses $(0.27) Estimate, Sales $4.20M Beat $4.02M Estimate
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.27) by 133.33 percent. This is a 12.5 percent decrease over losses of $(0.56) per share
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell
• Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Applied DNA to Deploy Linea 1.0 COVID-19 Assay For Rapid Detection Of New Omicron Subvariant BA.2
- Announcement Follows First Cases of BA.2 Identified in New York State Where the Majority of COVID-19 Testing Clients Reside -
- Linea 1.0 Assay’s Unique Double S-gene Target Design Likely Allows for the